PLRX icon

Pliant Therapeutics
PLRX

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$3
126% upside
High target

2 analyst ratings

positive
1  neutral
50%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Canaccord Genuity
Canaccord Genuity
Edward Nash
13 Mar ‘26 1 month ago
Piper Sandler
Piper Sandler
Yasmeen Rahimi
50% 1-yr PLRX win rate
12 Mar ‘26 1 month ago